More PRNewswire
View Older Stories View Newer Stories-
Resilience Expands Coverage for Technology Errors & Omissions Insurance for Clients Above $25M In Annual Revenue
-
CHMP Recommends EU Approval of BRINSUPRI™ (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis
-
WESTERN MIDSTREAM ANNOUNCES THIRD-QUARTER 2025 DISTRIBUTION AND EARNINGS CONFERENCE CALL
-
Nick Cohen, Doral Renewables' CEO, Honored by Goldman Sachs as one of the Most Exceptional Entrepreneurs at the 2025 Builders and Innovators Summit
-
Comerica Reports Third Quarter 2025 Earnings Results
-
A Journey to Elegant Life -- LEPAS Global Journey of Elegant Driving (China Stop) Concludes Successfully
-
Colossal's Toddler of the Year Campaign Raises $12.7 Million to Support Toys for Tots
-
Weekly Recap: 11 Finance Press Releases You Need to See
-
One Heung Kong Leads the Way! New Global Benchmark for Healthy Living Announced
-
Weekly Recap: 11 Tech Press Releases You Need to See
-
Omio's annual NowNext '25 report reveals a new era of intentional travel
-
BingX Achieves ISO 27001 Certification, Setting the Standard for Web3 Information Security
-
RhythmX AI Collaborates with Microsoft to Deliver Hyper-Personalized Care Through Dragon Copilot
-
Truist reports third quarter 2025 results
-
Weekly Recap: 14 Health Press Releases You Need to See
-
Erayak Power Solution Group Inc. Establishes U.S. Subsidiary to Advance Global Expansion and Reinforce Long-Term Growth Strategy
-
Weekly Recap: 13 Consumer Press Releases You Need to See
-
Yiren Digital Strategically Expands into Blockchain Finance and Partners with ChainUp for Platform Development
-
Minesto part of Swedish high-level delegation to South Korea
-
B2PRIME Accelerates Institutional Expansion with Strategic Hires from iSAM Securities
-
13 Press Releases You Need to See This Week
-
AEON Expands to Georgia with Local QR-Based Crypto Payments
-
GRAINGER ANNOUNCES AGREEMENT TO DIVEST CROMWELL
-
Hyperscale Data Declares Monthly Cash Dividend of $0.2708333 per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock
-
XAG Receives FAO Global Excellence in Sustainable Plant Production and Protection
-
Kelun-Biotech's Core product Trastuzumab Botidotin Approved for Marketing by NMPA for HER2-positive BC
-
SEMIFIVE Submits Securities Registration for KOSDAQ Listing
-
Bybit to List ZEROBASE (ZBT) on Spot
-
Huawei Unveils Upgraded AI WAN Solution with AI-Centric Architecture to Boost Carrier Growth
-
Life Time Launches a New Era of Luxury Wellness at Iconic Prudential Center with October 17 Opening of Urban Athletic Country Club
-
TriEye Unveils the Future of Tactical Vision at AUSA Washington
-
Parental Control App (2025): Qustodio Awarded Top Parental Control Solution in Report by Expert Consumers
-
Rebecca Rau Jewels Unveils the THEN & NOW Collection, a Fusion of Ancient Artifacts and Modern Adornment
-
Salama Shareholders Approve Landmark Capital Restructuring to Strengthen Solvency and Regulatory Capital Position
-
NEW ORIENTAL EDUCATION & TECHNOLOGY GROUP INC. TO HOLD ANNUAL GENERAL MEETING ON NOVEMBER 21, 2025
-
The 138th Canton Fair Opens with Emphasis on Innovation, Intelligence, and Sustainability
-
Florida Climate Week™ 2025 Drove Climate Action Statewide
-
Stellantis and Pony.ai Partner to Advance Robotaxi Development in Europe
-
Shanghai-London Screen Industry Forum Returns for Third Edition, Strengthening Sino-British Creative Ties and Showcasing Global Storytelling
-
Tomorrowland 2025: Overcoming Adversity with Unity
-
SIMAGIC at SimRacing Expo 2025: A Triple Reveal
-
Monport Treats Creators to Spooktacular Halloween Deals on Laser Engraving Machines
-
Pearson 2025 Nine Month Trading Update (Unaudited)
-
Julius Meinl Introduces Industrially Compostable Capsules to Award-Winning Organic Fairtrade Line at HostMilano
-
Renalys Pharma Reaches Japan PMDA Agreement on Phase III Clinical Trials of Sparsentan for Focal Segmental Glomerulosclerosis (FSGS) and Alport Syndrome (AS)
-
Roma Proclaim Sovereign Non-Territorial State in Haarlem
-
2nd World Conference on China Studies opens in Shanghai
-
Volvo Group - the third quarter 2025
-
FDA approves expanded pediatric indications for YUFLYMA® (adalimumab-aaty) and unbranded adalimumab-aaty in the United States
-
New First Presidency Discusses Key Issues and Shares Hopes for the World
